These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7597284)

  • 1. Properties of metastasizing and nonmetastasizing human melanoma cells.
    van Muijen GN; Danen EH; de Vries TJ; Quax PH; Verheijen JH; Ruiter DJ
    Recent Results Cancer Res; 1995; 139():105-22. PubMed ID: 7597284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells.
    Danen EH; van Muijen GN; van de Wiel-van Kemenade E; Jansen KF; Ruiter DJ; Figdor CG
    Int J Cancer; 1993 May; 54(2):315-21. PubMed ID: 8387465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
    Sugiura Y; Ma L; Sun B; Shimada H; Laug WE; Seeger RC; DeClerck YA
    Cancer Res; 1999 Mar; 59(6):1327-36. PubMed ID: 10096567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.
    Mueller BM
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():65-80. PubMed ID: 8814995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
    de Vries TJ; Quax PH; Denijn M; Verrijp KN; Verheijen JH; Verspaget HW; Weidle UH; Ruiter DJ; van Muijen GN
    Am J Pathol; 1994 Jan; 144(1):70-81. PubMed ID: 8291613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
    Meissauer A; Kramer MD; Hofmann M; Erkell LJ; Jacob E; Schirrmacher V; Brunner G
    Exp Cell Res; 1991 Feb; 192(2):453-9. PubMed ID: 1899072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion.
    Melchiori A; Mortarini R; Carlone S; Marchisio PC; Anichini A; Noonan DM; Albini A
    Exp Cell Res; 1995 Jul; 219(1):233-42. PubMed ID: 7628538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
    De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
    J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECM dependent and integrin mediated tumor cell migration of human glioma and melanoma cell lines under serum-free conditions.
    Goldbrunner RH; Haugland HK; Klein CE; Kerkau S; Roosen K; Tonn JC
    Anticancer Res; 1996; 16(6B):3679-87. PubMed ID: 9042241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins.
    Mortarini R; Anichini A; Parmiani G
    Int J Cancer; 1991 Feb; 47(4):551-9. PubMed ID: 1995484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of integrins in invasion of endometrial cancer cell lines.
    Prifti S; Zourab Y; Koumouridis A; Bohlmann M; Strowitzki T; Rabe T
    Gynecol Oncol; 2002 Jan; 84(1):12-20. PubMed ID: 11748970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
    de Vries TJ; Kitson JL; Silvers WK; Mintz B
    Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator production by human tumor cells: effect on tumor cell-extracellular matrix interactions.
    Varani J; McKeever PE; Fligiel SE; Sitrin RG
    Int J Cancer; 1987 Dec; 40(6):772-7. PubMed ID: 3692623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
    Czekay RP; Aertgeerts K; Curriden SA; Loskutoff DJ
    J Cell Biol; 2003 Mar; 160(5):781-91. PubMed ID: 12615913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin equivalent: an attractive model to evaluate early melanoma metastasis.
    Dekker SK; van Doorn R; Kempenaar J; Gruis NA; Vermeer BJ; Ponec M
    Melanoma Res; 2000 Apr; 10(2):127-40. PubMed ID: 10803713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro.
    Brooks TD; Slomp J; Quax PH; De Bart AC; Spencer MT; Verheijen JH; Charlton PA
    Clin Exp Metastasis; 2000; 18(6):445-53. PubMed ID: 11592301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin.
    Moser TL; Pizzo SV; Bafetti LM; Fishman DA; Stack MS
    Int J Cancer; 1996 Sep; 67(5):695-701. PubMed ID: 8782661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasminogen activation system in melanoma cell lines and in melanocytic lesions.
    de Vries TJ; van Muijen GN; Ruiter DJ
    Melanoma Res; 1996 Apr; 6(2):79-88. PubMed ID: 8791264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.